CHUGAI PHARMACEUTICAL CO., LTD The Nadeshiko Brand has been jointly implemented with METI and TSE since FY2012 to raise investors' attention to companies' efforts to empower women and further accelerating the efforts of listed companies by selecting listed companies that are outstanding in promoting women's active participation as attractive stocks that emphasize 'enhancing corporate value over the medium to long term.'
Specifically, companies that have passed certain screening criteria are evaluated in accordance with the scoring criteria for promoting women's active participation in the workplace, and the top companies in each industry are selected as a 'Nadeshiko Brand.'
This year's selection as a 'Nadeshiko Brand' follows four consecutive years of selection from FY2014 to FY 2017, as well as the selection in FY2020.
Chugai's basic policy is to grow and develop together with society with the aim to become a top innovator in the healthcare industry for advanced and sustainable patient-centric healthcare. Aiming to realize this goal, we have positioned the 'promotion of diversity and inclusion' as an important management issue so that diverse human resources can work actively and create new value. We believe that the selection of the 'Nadeshiko Brand' is a continuing recognition of our efforts to date.
Based on its basic philosophy that human resources are an invaluable asset that creates corporate growth and development, Chugai will continue developing a work environment and organizational culture that enables all employees to participate actively.
Contact:
Media
Tel: +81-3-3273-0881
E-mail: pr@chugai-pharm.co.jp
(C) 2022 Electronic News Publishing, source
